Skip to main content
Hemopurifier receives expedited pathway from FDA

The FDA has granted an expedited access pathway designation to Aethlon Medical's Aethlon Hemopurifier. The device is being developed for the removal of highly glycosylated viruses, and it has been studied in hepatitis C patients with end-stage renal disease.

Full Story: